IVF denied as not FDA-approved for this use by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for IVF are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UnitedHealthcare May Cite "Not FDA-Approved" for IVF

A "not FDA-approved" denial in the context of IVF is almost always a miscoding or a denial that conflates the IVF procedure itself with specific medications or laboratory techniques used during the cycle. IVF as a fertility treatment is a well-established, widely accepted medical procedure — not a drug — and does not require FDA approval in the same way a pharmaceutical product does. If UHC issued this denial reason for the IVF procedure itself, that is a strong basis for appeal based on incorrect denial categorization.

This denial may also arise when the cycle involves a specific embryo-handling technology, a genetic testing add-on (such as preimplantation genetic testing), or a compounded medication used during stimulation. In those situations, the "not FDA-approved" label attaches to the specific component, not the procedure as a whole.

## Your Federal Appeal Rights

• Internal appeal (ACA §2719 / ERISA §503): You have the right to a full-and-fair internal review. File in writing, within the timeframe on your denial letter. The plan must provide a complete copy of the clinical criteria used to make the determination.
• External review: After final internal denial, external review through an accredited IRO is available, generally within four months. External reviewers are well-positioned to correct a denial that misapplied a regulatory standard to a procedure rather than a drug.
• Expedited review: If your physician certifies that delay is harmful given the time-sensitive nature of your reproductive situation, request expedited external review (72-hour decision required).

## Documentation to Gather

1. Clarification of what was denied — request in writing from UHC the specific procedure code(s), device, or medication to which the "not FDA-approved" label was applied. This is your first step and often reveals a processing error. 2. Published medical/scientific support — your reproductive endocrinologist can provide a letter citing mainstream medical society statements (such as those from ASRM — the American Society for Reproductive Medicine) describing IVF as standard of care for diagnosed infertility. 3. Prescribing information for any medications — if the denial is actually about a stimulation medication or adjunct therapy, obtain the FDA-approved prescribing label for that drug and confirm whether the indication is on-label or off-label. Many fertility medications are used in well-supported off-label applications that UHC's own clinical policy may cover. 4. Diagnosis and treatment records — your full infertility workup, diagnosis, and prior treatment history, demonstrating why this specific treatment path was selected. 5. UHC's applicable coverage policy — download the current published policy for IVF and identify whether it applies a "not FDA-approved" exclusion to the procedure itself, and if so, on what clinical basis.

## Criteria-Mapping Structure

If the denial is based on a specific component of the IVF cycle, map the regulatory status of that component:

| Denied Item | Regulatory Status | Basis for Inclusion | |---|---|---| | IVF procedure itself | Established medical procedure, not a drug requiring FDA approval | ASRM guidelines, standard of care | | Stimulation medication (if at issue) | Confirm FDA-approval status from prescribing label | On-label or well-supported off-label use | | Adjunct technology (if at issue) | Confirm whether included in UHC's own coverage policy | Cross-reference UHC policy language |

Making this distinction explicit in your appeal letter is often sufficient to have this denial type reversed at the internal level.